Asia-Pacific Pen Needle Market Size, Share and Forecast 2020-2026

The Asia-Pacific pen needle market is anticipated to grow at a CAGR of 9.4% during the forecast period. The major factor influencing the growth of the market across Asia-Pacific include the increased prevalence of diabetes. The International Diabetes Federation (IDF) divided Asia-Pacific into South-East Asia and the Western Pacific. Among which, South-East Asia mainly includes India, Sri Lanka, and Bangladesh and as per IDF, around 88 million adults in the age range of 20-79 years were living with diabetes in South-East Asia in 2019. As per estimates, the total adult population with diabetes will reach around 153 million by 2045.

Further, advanced medical tourism and healthcare infrastructure across Asia-Pacific are also contributing significantly to the growth of the pen needle market. In addition to this, countries such as India, China, and Japan are investing significantly in the development of innovative therapeutic and medical devices including pen needles. This, in turn, will also drive the Asia-Pacific pen needle market.

To Request a Sample of our Report on Asia-Pacific Pen Needle Market: https://www.omrglobal.com/request-sample/asia-pacific-pen-needle-market

The Asia-Pacific pen needle market is segmented based on type, therapy, and mode of purchase. Based on the type, the market is sub-segmented into a standard pen needle and safety pen needle. The standard pen needles segment is estimated to contribute a significant share in the market. Based on the therapy, the market is sub-segmented into, insulin, GLP-1, growth hormones. Pen needles for insulin are estimated to contribute a prominent share in the market and are projected to do so during the forecast period. Based on the mode of purchase, the market is bifurcated into retail and non-retail. The retail segment is estimated to contribute significantly to market growth.

(Get 15% Discount on Buying this Report)

A full Report of Asia-Pacific Pen Needle Market is Available at: https://www.omrglobal.com/industry-reports/asia-pacific-pen-needle-market

Asia-Pacific Pen Needle Market Segmentation

By Type

· Standard Pen Needles

· Safety Pen Needles

By Therapy

· Insulin

· GLP-1

· Growth Hormones

By Mode of Purchase

· Retail

· Non-Retail

Regional Analysis

Asia-Pacific

· India

· China

· Japan

· South Korea

· Rest of APAC

Company Profiles

· B. Braun Melsungen AG

· Becton, Dickson, and Co.

· Berpu Medical Technology Co., Ltd.

· Hindustan Syringes & Medical Devices Ltd.

· MedExel Co., Ltd.

· Mylife(Ypsomed India Private Ltd.)

· Nanchang YiLi Medical Instrument Co.

· Nipro Corp.,

· Novo Nordisk A/S

· TerumoCorp.

Reasons to buy from us –

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/asia-pacific-pen-needle-market

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.